Dr. Abraham Avigdor, MD, is Director of the Institute of Hematology and Co‑Director of the Hematology & Bone Marrow Transplantation Division at Sheba Medical Center. He is an international leader in lymphoma, CAR‑T, and advanced hemato‑oncology with more than 35 years of experience. His clinical focus includes lymphomas, multiple myeloma, and complex blood cancers.
He is a pioneer in CAR‑T integration. He leads cellular therapy and bone marrow transplantation programs (autologous and allogeneic). He also advances stem cell therapies and precision diagnostics, including PET/CT‑based prognostics. His work includes immunotherapy and targeted regimens and the development of innovative, data‑driven protocols.
He collaborates with LYSA, EMCL, and international PET groups. He has authored more than 130 publications. Key roles include Founder and President of the Israeli Lymphoma Working Group, former Chair of the Israeli Lymphoma Study Group, and Senior Lecturer at Tel Aviv University. Education: MD, Ben‑Gurion University; residency, Sheba Medical Center; postdoctoral fellowship, Weizmann Institute. Awards include the Knesset Prize, the Israeli Ministry of Health Award, and the Sackler Prize.
Prof. Avichai Shimoni, MD, is Director of Bone Marrow Transplantation at Sheba Medical Center. He is a hemato-oncologist with over 30 years of experience in bone marrow transplantation, cellular therapies, and advanced blood cancer care.
He leads a high-volume program for complex, high-risk blood cancers. He performs allogeneic and autologous transplants. He also provides CAR T-cell therapy for leukemia, lymphoma, and multiple myeloma. He completed a bone marrow transplantation fellowship at MD Anderson Cancer Center.
He is Chairman of Hematology at Tel Aviv University and a Professor of Hematology. He has authored more than 250 scientific papers. His research focuses on CAR T-cell therapy and stem cell transplantation. He is often listed among Israel's Best Doctors (Forbes 2025 and 2026).
Dr. Hila Magen, MD, leads the Multiple Myeloma and Amyloidosis Unit at Sheba Medical Center. She is a hemato-oncologist with over 35 years of experience. She is a leading Israeli expert in multiple myeloma and plasma cell disorders.
She runs a program that provides personalized care and early access to clinical trials. This includes CAR-T therapy for high-risk and relapsed or refractory myeloma and amyloidosis. Dr. Magen is a principal investigator in point-of-care CAR-T studies. She brings new immunotherapies into routine care.
Training: Fellowships in Multiple Myeloma (UAMS) and Lymphocytic Leukemia (MD Anderson). Academic: Instructor, Tel Aviv University. Research: Author of 100+ publications, contributor to landmark myeloma studies, and reviewer for international journals.
Dr. Irina Zaidman spesialis dalam transplantasi sumsum tulang pediatrik – sebuah perawatan kritis untuk anemia aplastik – di Hadassah Medical Center.
Dr. Spielberg adalah seorang onkohematolog berdedikasi di Pusat Medis Assuta, yang berspesialisasi dalam gangguan darah seperti anemia aplastik.
Dr. Iris Kventsel, MD, is a pediatric hemato-oncologist and bone marrow transplant (BMT) specialist at Sheba Medical Center. She is an attending physician in the Pediatric Hemato-Oncology and BMT Division at the Edmond and Lily Safra Children’s Hospital. Her clinical focus is pediatric sarcomas, including Ewing sarcoma, osteosarcoma, and rhabdomyosarcoma.
She provides multidisciplinary care, including transplant and cellular therapies. She also uses current chemotherapy protocols and targeted therapies for complex childhood cancers.
Her research focuses on genetic cancer predisposition, including Li-Fraumeni syndrome, and cancer susceptibility genes. She has published in pediatric oncology, stem cell biology, and surgical oncology (HIPEC). She is on the academic staff at Tel Aviv University. Education: MD, Technion; Pediatrics residency, Assaf HaRofeh; Pediatric Hemato-Oncology fellowship, Sheba.
Prof. Dr. Serdar Bedii Omay telah menerbitkan lebih dari 65 artikel ilmiah tentang hematologi – berfokus pada perawatan tingkat lanjut di Rumah Sakit Emsey.
Associate Professor Rafet Eren spesialis dalam hematologi dengan 50+ publikasi di jurnal internasional, mencerminkan keahlian mendalam dalam gangguan darah.
Dr. Apak berspesialisasi dalam hematologi-onkologi anak dengan pengalaman lebih dari 30 tahun, berfokus pada transplantasi sumsum tulang dan terapi sel CAR-T di Rumah Sakit Universitas Biruni.
Spesialis dalam leukemia kronis dan penyakit mieloproliferatif, Dr. Dogu membawa keahlian hematologi yang luas ke Liv Hospital Ulus.
Prof. Fabio Ciceri memimpin Unit Hematologi dan Transplantasi Sumsum Tulang di Rumah Sakit Riset San Raffaele – sebuah pusat yang berspesialisasi dalam terapi lanjutan untuk kelainan darah.
Prof. Baytan berspesialisasi dalam hematologi dan onkologi pediatrik, dengan fokus pada kanker masa kanak-kanak dan transplantasi sumsum tulang di Rumah Sakit Emsey.
Kepala Pusat Transplantasi Sumsum Tulang di Rumah Sakit Universitas Essen – spesialis dalam onkohematologi.
Dr. Kalashetty spesialis dalam transplantasi sumsum tulang untuk anemia aplastik di Rumah Sakit Manipal.
Profesor Madya Ali Hakan Kaya berspesialisasi dalam hematologi dan transplantasi sel punca, dengan pelatihan ekstensif di rumah sakit terkemuka di Turki.
Spesialis dalam anemia aplastik dengan keahlian dalam transplantasi sumsum tulang – kunci utama untuk menangani kasus yang parah.
Ahli hematologi-onkologi anak yang berspesialisasi dalam anemia aplastik dan transplantasi sumsum tulang.